KETAMINE
Synapse Ketamine, a leading medical clinic in Richmond, Virginia, is at the forefront of offering innovative ketamine treatment for individuals suffering from depression, anxiety, and post-traumatic stress disorder (PTSD).
Backed by scientific studies demonstrating the potential efficacy of ketamine, Synapse Ketamine provides a safe and controlled environment for patients to receive this promising treatment.
With a focus on improving symptoms and enhancing overall well-being, Synapse Ketamine offers hope and relief to those who have found little success with traditional treatment methods. By embracing the transformative potential of ketamine therapy, Synapse Ketamine is empowering individuals in Richmond and beyond to find new paths toward mental health and recovery.
All new patients have a series of six infusions spaced over two or three weeks. Each infusion is 40 minutes long, painless, and well tolerated. Most patients experience significant relief during the series and many remain symptom free for extended periods of time following the initial treatment protocol.
Ketamine therapy impacts both mood and anxiety disorders with positive treatment outcomes for the following diagnoses:
-
Depression, Chronic Depression, and Treatment Resistant Depression
-
Post Traumatic Stress Disorder (PTSD)
-
Bipolar Disorder
-
Obsessive Compulsive Disorder (OCD)
-
Post Partum Depression
-
Most Anxiety Disorders
C. BRITT BEASLEY, MD
Dr. Beasley was born North Carolina and attended the University of North Carolina at Chapel Hill prior to moving to Richmond for graduate and medical school. He is board certified in Psychiatry and Addiction Medicine and holds a Doctorate of Medicine and Master's in Neurobiology from the Medical College of Virginia. He completed his residency in Psychiatry at Mount Sinai in New York and before holding a position as Clinical Associate in the Department of Psychiatry at the University of Pennsylvania.
Dr. Beasley's particular areas of interest include the treatment and neuroscience of stubborn psychiatric illness not responding to traditional medications including but not limited to post-traumatic stress disorder, treatment resistant depression, obsessive-compulsive disorder and substance use disorders.
PRACTICING SINCE 2010
BS, UNC-Chapel Hill
MD, VCU School of Medicine
Psychiatry Residency, Mount Sinai, New York